Immediate Impact

1 by Nobel laureates 1 from Science/Nature 64 standout
Sub-graph 1 of 22

Citing Papers

Ultrasound-Based Micro-/Nanosystems for Biomedical Applications
2024 Standout
The present and future of bispecific antibodies for cancer therapy
2024 Standout
2 intermediate papers

Works of Antonio Cubillo being referenced

Efficacy and Safety of Dilpacimab (ABT-165) versus Bevacizumab Plus Folfiri in Metastatic Colorectal Cancer: A Phase II Study
2022
A phase Ib study of the safety and efficacy of atezolizumab (atezo) + bevacizumab (bev) + cobimetinib (cobi) in patients (pts) with metastatic colorectal cancer (mCRC)
2019
and 1 more

Author Peers

Author Last Decade Papers Cites
Antonio Cubillo 838 246 228 241 87 1.1k
Antonia Digklia 436 313 209 204 61 1.1k
Anup Kasi 727 239 186 311 125 1.0k
Kohei Shigeta 573 203 151 248 73 904
Federica Recine 645 428 203 241 56 1.1k
Yeu‐Tsu N. Lee 609 338 175 187 56 1.0k
Neda A. Moatamed 596 168 303 314 77 1.3k
Qingguo Li 939 364 208 440 74 1.4k
Coraline Dubot 821 349 294 254 59 1.3k
Roberto Pazo-Cid 720 486 303 261 66 1.3k
Lujun Shen 391 299 248 223 91 1.1k

All Works

Loading papers...

Rankless by CCL
2026